Antacids Market Research Report by Formulation (Liquid, Powder, and Tablet), by Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents, and Proton Pump Inhibitor), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Antacids Market is expected to grow from USD 6,845.97 Million in 2020 to USD 8,370.15 Million by the end of 2025.
2. The Global Antacids Market is expected to grow from EUR 6,002.68 Million in 2020 to EUR 7,339.11 Million by the end of 2025.
3. The Global Antacids Market is expected to grow from GBP 5,336.39 Million in 2020 to GBP 6,524.48 Million by the end of 2025.
4. The Global Antacids Market is expected to grow from JPY 730,639.44 Million in 2020 to JPY 893,308.02 Million by the end of 2025.
5. The Global Antacids Market is expected to grow from AUD 9,941.27 Million in 2020 to AUD 12,154.58 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Antacids to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Liquid is projected to witness the highest growth during the forecast period'
'The Liquid is projected to witness the highest growth during the forecast period'
Based on Formulation, the Antacids Market studied across Liquid, Powder, and Tablet. The Tablet commanded the largest size in the Antacids Market in 2020. On the other hand, the Liquid is expected to grow at the fastest CAGR during the forecast period.
'The Proton Pump Inhibitor is projected to witness the highest growth during the forecast period'
'The Proton Pump Inhibitor is projected to witness the highest growth during the forecast period'
Based on Drug Class, the Antacids Market studied across Acid Neutralizers, H2 Antagonist, Promotility Agents, and Proton Pump Inhibitor. The H2 Antagonist commanded the largest size in the Antacids Market in 2020. On the other hand, the Proton Pump Inhibitor is expected to grow at the fastest CAGR during the forecast period.
'The Hospital Pharmacy is projected to witness the highest growth during the forecast period'
'The Hospital Pharmacy is projected to witness the highest growth during the forecast period'
Based on Distribution Channel, the Antacids Market studied across Hospital Pharmacy and Retail Pharmacy. The Retail Pharmacy commanded the largest size in the Antacids Market in 2020. On the other hand, the Hospital Pharmacy is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Antacids Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Antacids Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antacids Market including AstraZeneca PLC, Baxter Laboratories Pty Ltd., Bayer AG, Bodywise International LLC, C.H. Boehringer Sohn AG & Ko. KG, Cadila Pharmaceuticals Limited, GlaxoSmithKline PLC, GM Pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., Procter and Gamble Company, Sanofi S.A., Torrent Pharmaceuticals Ltd., and WellSpring Pharmaceutical Corporation.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Antacids Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Antacids Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antacids Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antacids Market?
4. What is the competitive strategic window for opportunities in the Global Antacids Market?
5. What are the technology trends and regulatory frameworks in the Global Antacids Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antacids Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Antacids Market is expected to grow from USD 6,845.97 Million in 2020 to USD 8,370.15 Million by the end of 2025.
2. The Global Antacids Market is expected to grow from EUR 6,002.68 Million in 2020 to EUR 7,339.11 Million by the end of 2025.
3. The Global Antacids Market is expected to grow from GBP 5,336.39 Million in 2020 to GBP 6,524.48 Million by the end of 2025.
4. The Global Antacids Market is expected to grow from JPY 730,639.44 Million in 2020 to JPY 893,308.02 Million by the end of 2025.
5. The Global Antacids Market is expected to grow from AUD 9,941.27 Million in 2020 to AUD 12,154.58 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Antacids to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Liquid is projected to witness the highest growth during the forecast period'
'The Liquid is projected to witness the highest growth during the forecast period'
Based on Formulation, the Antacids Market studied across Liquid, Powder, and Tablet. The Tablet commanded the largest size in the Antacids Market in 2020. On the other hand, the Liquid is expected to grow at the fastest CAGR during the forecast period.
'The Proton Pump Inhibitor is projected to witness the highest growth during the forecast period'
'The Proton Pump Inhibitor is projected to witness the highest growth during the forecast period'
Based on Drug Class, the Antacids Market studied across Acid Neutralizers, H2 Antagonist, Promotility Agents, and Proton Pump Inhibitor. The H2 Antagonist commanded the largest size in the Antacids Market in 2020. On the other hand, the Proton Pump Inhibitor is expected to grow at the fastest CAGR during the forecast period.
'The Hospital Pharmacy is projected to witness the highest growth during the forecast period'
'The Hospital Pharmacy is projected to witness the highest growth during the forecast period'
Based on Distribution Channel, the Antacids Market studied across Hospital Pharmacy and Retail Pharmacy. The Retail Pharmacy commanded the largest size in the Antacids Market in 2020. On the other hand, the Hospital Pharmacy is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Antacids Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Antacids Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Antacids Market including AstraZeneca PLC, Baxter Laboratories Pty Ltd., Bayer AG, Bodywise International LLC, C.H. Boehringer Sohn AG & Ko. KG, Cadila Pharmaceuticals Limited, GlaxoSmithKline PLC, GM Pharmaceuticals, Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., Procter and Gamble Company, Sanofi S.A., Torrent Pharmaceuticals Ltd., and WellSpring Pharmaceutical Corporation.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Antacids Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Antacids Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antacids Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antacids Market?
4. What is the competitive strategic window for opportunities in the Global Antacids Market?
5. What are the technology trends and regulatory frameworks in the Global Antacids Market?
6. What are the modes and strategic moves considered suitable for entering the Global Antacids Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Distribution Channel Outlook
3.5. Formulation Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing population suffering from gastroesophageal reflux disease, or GERD due to unhealthy lifestyle choices and consumption of drugs resulting in acidity
5.1.1.2. Availability of information creating awareness about GERD
5.1.1.3. Sedentary and stressed lifestyle necessitates demanding antacids
5.1.2. Restraints
5.1.2.1. Home remedies and other alternatives for acidity related issues
5.1.3. Opportunities
5.1.3.1. Development of more instantly effective and long lasting antacids
5.1.3.2. Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs
5.1.4. Challenges
5.1.4.1. FDA drug recall due to significant health side effects associated with the antacids
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANTACIDS MARKET, BY FORMULATION
6.1. Introduction
6.2. Liquid
6.3. Powder
6.4. Tablet
7. GLOBAL ANTACIDS MARKET, BY DRUG CLASS
7.1. Introduction
7.2. Acid Neutralizers
7.3. H2 Antagonist
7.4. Promotility Agents
7.5. Proton Pump Inhibitor
8. GLOBAL ANTACIDS MARKET, BY DISTRIBUTION CHANNEL
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Retail Pharmacy
9. AMERICAS ANTACIDS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC ANTACIDS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. AstraZeneca PLC
13.2. Baxter Laboratories Pty Ltd.
13.3. Bayer AG
13.4. Bodywise International LLC
13.5. C.H. Boehringer Sohn AG & Ko. KG
13.6. Cadila Pharmaceuticals Limited
13.7. GlaxoSmithKline PLC
13.8. GM Pharmaceuticals, Inc.
13.9. Johnson & Johnson
13.10. Novartis AG
13.11. Pfizer Inc.
13.12. Procter and Gamble Company
13.13. Sanofi S.A.
13.14. Torrent Pharmaceuticals Ltd.
13.15. WellSpring Pharmaceutical Corporation
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Distribution Channel Outlook
3.5. Formulation Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing population suffering from gastroesophageal reflux disease, or GERD due to unhealthy lifestyle choices and consumption of drugs resulting in acidity
5.1.1.2. Availability of information creating awareness about GERD
5.1.1.3. Sedentary and stressed lifestyle necessitates demanding antacids
5.1.2. Restraints
5.1.2.1. Home remedies and other alternatives for acidity related issues
5.1.3. Opportunities
5.1.3.1. Development of more instantly effective and long lasting antacids
5.1.3.2. Easy availability of antacids in the online pharmacy and regulation flexibility for OTC drugs
5.1.4. Challenges
5.1.4.1. FDA drug recall due to significant health side effects associated with the antacids
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANTACIDS MARKET, BY FORMULATION
6.1. Introduction
6.2. Liquid
6.3. Powder
6.4. Tablet
7. GLOBAL ANTACIDS MARKET, BY DRUG CLASS
7.1. Introduction
7.2. Acid Neutralizers
7.3. H2 Antagonist
7.4. Promotility Agents
7.5. Proton Pump Inhibitor
8. GLOBAL ANTACIDS MARKET, BY DISTRIBUTION CHANNEL
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Retail Pharmacy
9. AMERICAS ANTACIDS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC ANTACIDS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. AstraZeneca PLC
13.2. Baxter Laboratories Pty Ltd.
13.3. Bayer AG
13.4. Bodywise International LLC
13.5. C.H. Boehringer Sohn AG & Ko. KG
13.6. Cadila Pharmaceuticals Limited
13.7. GlaxoSmithKline PLC
13.8. GM Pharmaceuticals, Inc.
13.9. Johnson & Johnson
13.10. Novartis AG
13.11. Pfizer Inc.
13.12. Procter and Gamble Company
13.13. Sanofi S.A.
13.14. Torrent Pharmaceuticals Ltd.
13.15. WellSpring Pharmaceutical Corporation
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANTACIDS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANTACIDS MARKET VOLUME, 2018-2025 (KILOTON)
TABLE 4. GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANTACIDS MARKET VOLUME, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 6. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 8. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANTACIDS MARKET VOLUME, BY LIQUID, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 10. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANTACIDS MARKET VOLUME, BY POWDER, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 12. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANTACIDS MARKET VOLUME, BY TABLET, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 14. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 16. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANTACIDS MARKET VOLUME, BY ACID NEUTRALIZERS, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 18. GLOBAL ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ANTACIDS MARKET VOLUME, BY H2 ANTAGONIST, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 20. GLOBAL ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL ANTACIDS MARKET VOLUME, BY PROMOTILITY AGENTS, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 22. GLOBAL ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL ANTACIDS MARKET VOLUME, BY PROTON PUMP INHIBITOR, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 24. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 26. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL ANTACIDS MARKET VOLUME, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 28. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL ANTACIDS MARKET VOLUME, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 30. AMERICAS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS ANTACIDS MARKET VOLUME, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 32. AMERICAS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 34. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 36. AMERICAS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 38. ARGENTINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 40. ARGENTINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 42. ARGENTINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ARGENTINA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 44. BRAZIL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 46. BRAZIL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. BRAZIL ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 48. BRAZIL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. BRAZIL ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 50. CANADA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CANADA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 52. CANADA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CANADA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 54. CANADA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CANADA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 56. MEXICO ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MEXICO ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 58. MEXICO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MEXICO ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 60. MEXICO ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MEXICO ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 62. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. UNITED STATES ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 64. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. UNITED STATES ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 66. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED STATES ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 68. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. ASIA-PACIFIC ANTACIDS MARKET VOLUME, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 70. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. ASIA-PACIFIC ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 72. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. ASIA-PACIFIC ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 74. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. ASIA-PACIFIC ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 76. AUSTRALIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. AUSTRALIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 78. AUSTRALIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. AUSTRALIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 80. AUSTRALIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. AUSTRALIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 82. CHINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. CHINA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 84. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. CHINA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 86. CHINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. CHINA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 88. INDIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. INDIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 90. INDIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. INDIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 92. INDIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. INDIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 94. INDONESIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. INDONESIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 96. INDONESIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. INDONESIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 98. INDONESIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. INDONESIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 100. JAPAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. JAPAN ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 102. JAPAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. JAPAN ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 104. JAPAN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. JAPAN ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 106. MALAYSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. MALAYSIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 108. MALAYSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. MALAYSIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 110. MALAYSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. MALAYSIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 112. PHILIPPINES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. PHILIPPINES ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 114. PHILIPPINES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. PHILIPPINES ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 116. PHILIPPINES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. PHILIPPINES ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 118. SOUTH KOREA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH KOREA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 120. SOUTH KOREA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH KOREA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 122. SOUTH KOREA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH KOREA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 124. THAILAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. THAILAND ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 126. THAILAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. THAILAND ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 128. THAILAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. THAILAND ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET VOLUME, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 138. FRANCE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. FRANCE ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 140. FRANCE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. FRANCE ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 142. FRANCE ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. FRANCE ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 144. GERMANY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. GERMANY ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 146. GERMANY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. GERMANY ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 148. GERMANY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. GERMANY ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 150. ITALY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. ITALY ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 152. ITALY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. ITALY ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 154. ITALY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. ITALY ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 156. NETHERLANDS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. NETHERLANDS ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 158. NETHERLANDS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. NETHERLANDS ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 160. NETHERLANDS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. NETHERLANDS ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 162. QATAR ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. QATAR ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 164. QATAR ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 165. QATAR ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 166. QATAR ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 167. QATAR ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 168. RUSSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 169. RUSSIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 170. RUSSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 171. RUSSIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 172. RUSSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 173. RUSSIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 174. SAUDI ARABIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 175. SAUDI ARABIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 176. SAUDI ARABIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 177. SAUDI ARABIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 178. SAUDI ARABIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 179. SAUDI ARABIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 180. SOUTH AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 181. SOUTH AFRICA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 182. SOUTH AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 183. SOUTH AFRICA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 184. SOUTH AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 185. SOUTH AFRICA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 186. SPAIN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 187. SPAIN ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 188. SPAIN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 189. SPAIN ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 190. SPAIN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 191. SPAIN ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 192. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 193. UNITED ARAB EMIRATES ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 194. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 195. UNITED ARAB EMIRATES ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 196. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 197. UNITED ARAB EMIRATES ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 198. UNITED KINGDOM ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 199. UNITED KINGDOM ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 200. UNITED KINGDOM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 201. UNITED KINGDOM ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 202. UNITED KINGDOM ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 203. UNITED KINGDOM ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 204. GLOBAL ANTACIDS MARKET: SCORES
TABLE 205. GLOBAL ANTACIDS MARKET: BUSINESS STRATEGY
TABLE 206. GLOBAL ANTACIDS MARKET: PRODUCT SATISFACTION
TABLE 207. GLOBAL ANTACIDS MARKET: RANKING
TABLE 208. GLOBAL ANTACIDS MARKET: MERGER & ACQUISITION
TABLE 209. GLOBAL ANTACIDS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 210. GLOBAL ANTACIDS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 211. GLOBAL ANTACIDS MARKET: INVESTMENT & FUNDING
TABLE 212. GLOBAL ANTACIDS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 213. GLOBAL ANTACIDS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANTACIDS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANTACIDS MARKET VOLUME, 2018-2025 (KILOTON)
TABLE 4. GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANTACIDS MARKET VOLUME, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 6. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 8. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANTACIDS MARKET VOLUME, BY LIQUID, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 10. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANTACIDS MARKET VOLUME, BY POWDER, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 12. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANTACIDS MARKET VOLUME, BY TABLET, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 14. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 16. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANTACIDS MARKET VOLUME, BY ACID NEUTRALIZERS, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 18. GLOBAL ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ANTACIDS MARKET VOLUME, BY H2 ANTAGONIST, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 20. GLOBAL ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL ANTACIDS MARKET VOLUME, BY PROMOTILITY AGENTS, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 22. GLOBAL ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL ANTACIDS MARKET VOLUME, BY PROTON PUMP INHIBITOR, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 24. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 26. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL ANTACIDS MARKET VOLUME, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 28. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL ANTACIDS MARKET VOLUME, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 30. AMERICAS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS ANTACIDS MARKET VOLUME, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 32. AMERICAS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 34. AMERICAS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 36. AMERICAS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 38. ARGENTINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ARGENTINA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 40. ARGENTINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 42. ARGENTINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ARGENTINA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 44. BRAZIL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. BRAZIL ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 46. BRAZIL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. BRAZIL ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 48. BRAZIL ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. BRAZIL ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 50. CANADA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CANADA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 52. CANADA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CANADA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 54. CANADA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CANADA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 56. MEXICO ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MEXICO ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 58. MEXICO ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MEXICO ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 60. MEXICO ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MEXICO ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 62. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. UNITED STATES ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 64. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. UNITED STATES ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 66. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED STATES ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 68. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. ASIA-PACIFIC ANTACIDS MARKET VOLUME, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 70. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. ASIA-PACIFIC ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 72. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. ASIA-PACIFIC ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 74. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. ASIA-PACIFIC ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 76. AUSTRALIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. AUSTRALIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 78. AUSTRALIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. AUSTRALIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 80. AUSTRALIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. AUSTRALIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 82. CHINA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. CHINA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 84. CHINA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. CHINA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 86. CHINA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. CHINA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 88. INDIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. INDIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 90. INDIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. INDIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 92. INDIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. INDIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 94. INDONESIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. INDONESIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 96. INDONESIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. INDONESIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 98. INDONESIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. INDONESIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 100. JAPAN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. JAPAN ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 102. JAPAN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. JAPAN ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 104. JAPAN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. JAPAN ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 106. MALAYSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. MALAYSIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 108. MALAYSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. MALAYSIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 110. MALAYSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. MALAYSIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 112. PHILIPPINES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. PHILIPPINES ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 114. PHILIPPINES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. PHILIPPINES ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 116. PHILIPPINES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. PHILIPPINES ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 118. SOUTH KOREA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH KOREA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 120. SOUTH KOREA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH KOREA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 122. SOUTH KOREA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH KOREA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 124. THAILAND ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. THAILAND ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 126. THAILAND ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. THAILAND ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 128. THAILAND ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. THAILAND ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET VOLUME, BY GEOGRAPHY, 2018-2025 (KILOTON)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 138. FRANCE ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. FRANCE ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 140. FRANCE ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. FRANCE ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 142. FRANCE ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. FRANCE ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 144. GERMANY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. GERMANY ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 146. GERMANY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. GERMANY ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 148. GERMANY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. GERMANY ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 150. ITALY ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. ITALY ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 152. ITALY ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. ITALY ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 154. ITALY ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. ITALY ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 156. NETHERLANDS ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. NETHERLANDS ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 158. NETHERLANDS ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. NETHERLANDS ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 160. NETHERLANDS ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. NETHERLANDS ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 162. QATAR ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. QATAR ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 164. QATAR ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 165. QATAR ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 166. QATAR ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 167. QATAR ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 168. RUSSIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 169. RUSSIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 170. RUSSIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 171. RUSSIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 172. RUSSIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 173. RUSSIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 174. SAUDI ARABIA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 175. SAUDI ARABIA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 176. SAUDI ARABIA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 177. SAUDI ARABIA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 178. SAUDI ARABIA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 179. SAUDI ARABIA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 180. SOUTH AFRICA ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 181. SOUTH AFRICA ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 182. SOUTH AFRICA ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 183. SOUTH AFRICA ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 184. SOUTH AFRICA ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 185. SOUTH AFRICA ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 186. SPAIN ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 187. SPAIN ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 188. SPAIN ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 189. SPAIN ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 190. SPAIN ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 191. SPAIN ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 192. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 193. UNITED ARAB EMIRATES ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 194. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 195. UNITED ARAB EMIRATES ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 196. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 197. UNITED ARAB EMIRATES ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 198. UNITED KINGDOM ANTACIDS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 199. UNITED KINGDOM ANTACIDS MARKET VOLUME, BY DRUG CLASS, 2018-2025 (KILOTON)
TABLE 200. UNITED KINGDOM ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 201. UNITED KINGDOM ANTACIDS MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2018-2025 (KILOTON)
TABLE 202. UNITED KINGDOM ANTACIDS MARKET SIZE, BY FORMULATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 203. UNITED KINGDOM ANTACIDS MARKET VOLUME, BY FORMULATION, 2018-2025 (KILOTON)
TABLE 204. GLOBAL ANTACIDS MARKET: SCORES
TABLE 205. GLOBAL ANTACIDS MARKET: BUSINESS STRATEGY
TABLE 206. GLOBAL ANTACIDS MARKET: PRODUCT SATISFACTION
TABLE 207. GLOBAL ANTACIDS MARKET: RANKING
TABLE 208. GLOBAL ANTACIDS MARKET: MERGER & ACQUISITION
TABLE 209. GLOBAL ANTACIDS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 210. GLOBAL ANTACIDS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 211. GLOBAL ANTACIDS MARKET: INVESTMENT & FUNDING
TABLE 212. GLOBAL ANTACIDS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 213. GLOBAL ANTACIDS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ANTACIDS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTACIDS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTACIDS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL ANTACIDS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ANTACIDS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ANTACIDS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2020 VS 2025 (%)
FIGURE 15. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2025
FIGURE 17. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 21. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 23. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
FIGURE 28. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 30. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 32. AMERICAS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. AMERICAS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. ARGENTINA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. BRAZIL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. CANADA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. MEXICO ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. UNITED STATES ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. AUSTRALIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CHINA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDONESIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. JAPAN ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. MALAYSIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. PHILIPPINES ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SOUTH KOREA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. THAILAND ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. FRANCE ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. GERMANY ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. ITALY ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. NETHERLANDS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. QATAR ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. RUSSIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SAUDI ARABIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SOUTH AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SPAIN ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED KINGDOM ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. GLOBAL ANTACIDS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL ANTACIDS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 68. GLOBAL ANTACIDS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTACIDS MARKET, BY TYPE
FIGURE 1. GLOBAL ANTACIDS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTACIDS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTACIDS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL ANTACIDS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ANTACIDS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ANTACIDS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2020 VS 2025 (%)
FIGURE 15. GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTACIDS MARKET SIZE, BY FORMULATION, 2025
FIGURE 17. GLOBAL ANTACIDS MARKET SIZE, BY LIQUID, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ANTACIDS MARKET SIZE, BY POWDER, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTACIDS MARKET SIZE, BY TABLET, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 21. GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTACIDS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 23. GLOBAL ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANTACIDS MARKET SIZE, BY PROMOTILITY AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
FIGURE 28. GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 30. GLOBAL ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, 2020 VS 2025 (USD MILLION)
FIGURE 32. AMERICAS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. AMERICAS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. ARGENTINA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. BRAZIL ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. CANADA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. MEXICO ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. UNITED STATES ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. ASIA-PACIFIC ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. AUSTRALIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. CHINA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. INDIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. INDONESIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. JAPAN ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. MALAYSIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. PHILIPPINES ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. SOUTH KOREA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. THAILAND ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 55. FRANCE ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. GERMANY ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. ITALY ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. NETHERLANDS ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. QATAR ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. RUSSIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SAUDI ARABIA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. SOUTH AFRICA ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. SPAIN ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. UNITED ARAB EMIRATES ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. UNITED KINGDOM ANTACIDS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. GLOBAL ANTACIDS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL ANTACIDS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 68. GLOBAL ANTACIDS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTACIDS MARKET, BY TYPE
